Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 220 S Orange Ave LIVINGSTON NJ 07039-5804 |
Tel: | N/A |
Website: | https://www.milestonescientific.com |
IR: | See website |
Key People | ||
Jan Arjan Haverhals President, Chief Executive Officer, Director, Chief Executive Office of Milestone Dental Division | Leonard A. Osser Vice Chairman of the Board |
Business Overview |
Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries. |
Financial Overview |
For the fiscal year ended 31 December 2023, Milestone Scientific Inc revenues increased 12% to $9.8M. Net loss decreased 20% to $6.9M. Revenues reflect Medical segment increase of 25% to $66K, Domestic-US and Canada segment increase of 63% to $5.4M. Lower net loss reflects Medical segment loss decrease of 23% to $3.7M, Dental segment income increase of 90% to $2.1M. |
Employees: | 17 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $45.40M as of Dec 31, 2023 |
Annual revenue (TTM): | $9.83M as of Dec 31, 2023 |
EBITDA (TTM): | -$7.04M as of Dec 31, 2023 |
Net annual income (TTM): | -$6.93M as of Dec 31, 2023 |
Free cash flow (TTM): | -$5.33M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 76,602,116 as of Mar 29, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |